| Literature DB >> 24900419 |
Piia Kokkonen1, Minna Rahnasto-Rilla1, Päivi H Kiviranta1, Tero Huhtiniemi1, Tuomo Laitinen1, Antti Poso1, Elina Jarho1, Maija Lahtela-Kakkonen1.
Abstract
SIRT6 belongs to the family of histone deacetylases (class III), but it also has mono-ADP-ribosyltransferase activity. SIRT6 is a nuclear sirtuin that has been associated with aging, cellular protection, and sugar metabolism. Despite these important roles for SIRT6, thus far, there are only a few weak SIRT6 inhibitors available, and no structure-activity relationship (SAR) studies have been published. This is the first study concerning peptides and pseudopeptides as SIRT6 deacetylation inhibitors and the first SAR data concerning SIRT6. We also investigated the molecular interactions using a homology model. We report three compounds exhibiting 62-91% SIRT6 inhibition at 200 μM concentration. These compounds can serve as starting points for systematic SAR studies and SIRT6 inhibitor design.Entities:
Keywords: SIRT6; inhibitor; peptide; pseudopeptide; sirtuin; substrate-based inhibitor
Year: 2012 PMID: 24900419 PMCID: PMC4025866 DOI: 10.1021/ml300139n
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345